[1]
2026. Epigenetic Regulators and Response to Hypomethylating Agents in Higher-Risk Myelodysplastic Syndromes. Annals of Leukemia Research. 7, 1 (Jul. 2026), 7–12. DOI:https://doi.org/10.5281/zenodo.22247708.